Mecasermin
Modify Date: 2024-01-11 12:48:17
Mecasermin structure
|
Common Name | Mecasermin | ||
|---|---|---|---|---|
| CAS Number | 68562-41-4 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of MecaserminMecasermin (Human IGF-I; FK 780) is a recombinant human insulin-like growth factor I (IGF-I). Mecasermin has the potential for the study of the growth failure of growth hormone (GH) insensitivity caused by GH receptor defects or GH-inhibiting antibodies[1]. |
| Name | Mecasermin |
|---|
| Description | Mecasermin (Human IGF-I; FK 780) is a recombinant human insulin-like growth factor I (IGF-I). Mecasermin has the potential for the study of the growth failure of growth hormone (GH) insensitivity caused by GH receptor defects or GH-inhibiting antibodies[1]. |
|---|---|
| Related Catalog | |
| In Vivo | Mecasermin (rhIGF1; 0.25 mg/kg; i.p.; daily; 6 weeks) 可将血清中的 IGF1 浓度提高至接近正常水平，并改善多种表型，包括机体和行为功能、突触和回路可塑性、神经元结构和分子信号通路[2]。 Animal Model: Mecp2 hemizygous KO mice[2] Dosage: 0.25 mg/kg Administration: i.p.; daily; 6 weeks Result: Improved lifespan, locomotor activity, heart rate, respiration patterns, and social and anxiety behavior. |
| References |
| No Any Chemical & Physical Properties |